Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 5/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.50 |
| ▸ | CSF1R | P07333 | 1/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.35 |
| ▸ | ABCC1 | P33527 | 4/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.34 |
| ▸ | PRKDC | P78527 | 2/20 | 0.33 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.33 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | PDE5A | O76074 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20109574 | 0.92 | LIPG (0.60) | LPLLIPGCSF1RABCB1ABCG2 | |
| SCHEMBL22087264 | 0.91 | LIPG (0.50) | LPLLIPGCSF1RABCB1ABCG2 | |
| SCHEMBL18090641 | 0.91 | LPL (0.49) | LPLLIPGCSF1RABCB1ABCG2 | |
| SCHEMBL24239226 | 0.90 | LIPG (0.49) | LPLLIPGCSF1RKMT2AKDM4E | |
| SCHEMBL18164752 | 0.90 | LIPG (0.48) | LPLLIPGCSF1RABCB1ABCG2 | |
| SCHEMBL19832039 | 0.90 | LPL (0.48) | LPLLIPGCSF1RABCB1ABCG2 | |
| SCHEMBL17807008 | 0.89 | LPL (0.49) | LPLLIPGCSF1RABCB1ABCG2 | |
| SCHEMBL19960893 | 0.89 | LIPG (0.61) | LPLLIPGCSF1RABCB1ABCG2 | |
| SCHEMBL24264177 | 0.88 | LIPG (0.49) | LPLLIPGCSF1RKMT2AKDM4E | |
| SCHEMBL22161103 | 0.87 | LIPG (0.56) | LPLLIPGCSF1RKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| US-20220037594-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230115134-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | LPL 3264/4885LIPG 1322/4885CSF1R 4263/4885 |
| US-11800795-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | PIEZO1, ORAI2, OCIAD1 | LPL 2953/4885LIPG 1225/4885CSF1R 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.